A plasma cytokine and angiogenic factor (CAF) analysis for selection of bevacizumab therapy in patients with metastatic colorectal cancer

This study intends to identify biomarkers that could refine the selection of patients with metastatic colorectal cancer (mCRC) for bevacizumab treatment. Pretreatment 36 plasma cytokines and angiogenic factors (CAFs) were first measured by protein microarray analysis in patients who received first-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Long, Wang, Feng, Zhang, Dong-sheng, Li, Cong, Jin, Ying, Wang, De-shen, Chen, Dong-liang, Qiu, Miao-zhen, Luo, Hui-yan, Wang, Zhi-qiang, Li, Yu-hong, Wang, Feng-hua, Xu, Rui-hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664961/
https://www.ncbi.nlm.nih.gov/pubmed/26620439
http://dx.doi.org/10.1038/srep17717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664961/
https://www.ncbi.nlm.nih.gov/pubmed/26620439
http://dx.doi.org/10.1038/srep17717

Ejemplares similares